TEVA PHARMACEUTICAL INDUSTRIES LTD Business Finance Contracts & Agreements
28 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (4)
- Deposit Agreements (1)
- Indenture Agreements (10)
- Loan Agreements (6)
- Registration Rights Agreements (4)
- Underwriting Agreements (2)
- Second Amendment to Senior Unsecured Sustainability-Linked Revolving Credit Agreement, dated May 3, 2024, by and among Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals... (Filed With SEC on May 8, 2024)
- Fourth Supplemental Senior Indenture, dated as of March 9, 2023, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New... (Filed With SEC on March 9, 2023)
- Fourth Supplemental Senior Indenture, dated as of March 9, 2023, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on March 9, 2023)
- Underwriting Agreement, dated as of March 1, 2023, among the Issuers, the Company, Citigroup Global Markets Europe AG, Citigroup Global Markets Inc., Goldman Sachs Bank Europe SE,... (Filed With SEC on March 3, 2023)
- Amendment to Senior Unsecured Sustainability-Linked Revolving Credit Agreement, dated as of February 6, 2023, by and among Teva Pharmaceutical Industries Limited, Teva... (Filed With SEC on February 10, 2023)
- Third Supplemental Senior Indenture, dated as of November 9, 2021, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of... (Filed With SEC on November 10, 2021)
- Third Supplemental Senior Indenture, dated as of November 9, 2021, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on November 10, 2021)
- Underwriting Agreement, dated as of November 2, 2021, among the Issuers, the Company, BNP Paribas, BNP Paribas Securities Corp., BofA Securities Europe SA, BofA Securities, Inc.,... (Filed With SEC on November 4, 2021)
- Registration Rights Agreement, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and the initial... (Filed With SEC on November 25, 2019)
- Second Supplemental Senior Indenture, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of... (Filed With SEC on November 25, 2019)
- Registration Rights Agreement, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited and the initial... (Filed With SEC on November 25, 2019)
- Second Supplemental Senior Indenture, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on November 25, 2019)
- Second Amended and Restated Deposit Agreement, by and among Teva Pharmaceutical Industries Limited and Citibank, N.A., as Depositary, and the holders and beneficial owners of... (Filed With SEC on December 4, 2018)
- Long-Term Assignment Letter for Michael McClellan dated August 9, 2018 (Filed With SEC on November 1, 2018)
- Registration Rights Agreement, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited and the initial purchasers... (Filed With SEC on March 14, 2018)
- First Supplemental Senior Indenture, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on March 14, 2018)
- Senior Indenture, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon, as... (Filed With SEC on March 14, 2018)
- Registration Rights Agreement, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and the initial... (Filed With SEC on March 14, 2018)
- First Supplemental Senior Indenture, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New... (Filed With SEC on March 14, 2018)
- Senior Indenture, dated as of March 14, 2018, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon, as... (Filed With SEC on March 14, 2018)
- Amendment, dated as of July 21, 2016, to the Senior Unsecured Revolving Credit Agreement, dated as of November 16, 2015, by and among Teva Pharmaceutical Industries Limited, as... (Filed With SEC on February 12, 2018)
- Amendment, dated as of September 24, 2015, to the Senior Unsecured Japanese Yen Term Loan Credit Agreement, dated as of December 17, 2013, among Teva Pharmaceutical Industries... (Filed With SEC on February 12, 2018)
- Amendment, dated as of September 24, 2015, to the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement, dated as of March 28, 2012, among Teva Pharmaceutical... (Filed With SEC on February 12, 2018)
- Amendment to the Senior Unsecured Japanese Yen Term Loan Credit Agreement, dated as of March 22, 2017 (Filed With SEC on February 1, 2018)
- Amendment to the Senior Unsecured Japanese Yen Term Loan Credit Agreement, dated as of December 17, 2013 (Filed With SEC on February 1, 2018)
- Amendment to the Senior Unsecured Fixed Rate Japanese Yen Term Loan Credit Agreement, dated as of March 28, 2012 (Filed With SEC on February 1, 2018)
- Amendment to the Term Loan Credit Agreement dated as of November 16, 2015 (Filed With SEC on February 1, 2018)
- Amendment to the Senior Unsecured Revolving Credit Agreement dated as of November 16, 2015 (Filed With SEC on February 1, 2018)
